You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fosaprepitant

Showing 1 - 25 of 76
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Postoperative Nausea and Vomiting, Gynecologic Surgical Procedures, Laparoscopy Trial (fosaprepitant, normal saline)

Not yet recruiting
  • Postoperative Nausea and Vomiting
  • +2 more
  • fosaprepitant
  • normal saline
  • (no location specified)
Mar 16, 2023

Tumors Trial in Xi'an (Fosaprepitant Dimeglumine for Injection)

Recruiting
  • Neoplasms
  • Fosaprepitant Dimeglumine for Injection
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Air Force Military Medical Univ
Feb 22, 2023

Postoperative Nausea and Vomiting, Anesthesia Complication, Thoracic Diseases Trial (Ondansetron 8mg, Fosaprepitant 150 mg)

Not yet recruiting
  • Postoperative Nausea and Vomiting
  • +2 more
  • Ondansetron 8mg
  • Fosaprepitant 150 mg
  • (no location specified)
Jun 4, 2023

Chemo-induced Nausea and Vomiting Trial in Henan, Zhengzhou (Fosaprepitant , Tropisetron and Olanzapine, Fosaprepitant ,

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Fosaprepitant , Tropisetron and Olanzapine
  • Fosaprepitant , Tropisetron, Dexamethasoneand Olanzapine
  • Henan, Henan, China
  • +1 more
Apr 11, 2022

Cervical Cancer, Nasopharyngeal Cancer, Chemo-induced Nausea and Vomiting Trial in Shantou (Fosaprepitant, tropisetron,

Recruiting
  • Cervical Cancer
  • +4 more
  • Fosaprepitant
  • +2 more
  • Shantou, Guangdong, China
    Cancer Hospital of Shantou University Medical College
Sep 29, 2022

C.Surgical Procedure; Gastrointestinal Trial in Guangzhou (palonosteron, dexamethasone, and fosaprepitant dissolved in 0.9%

Completed
  • C.Surgical Procedure; Gastrointestinal
  • palonosetron, dexamethasone, and fosaprepitant dissolved in 0.9% NaCl
  • palonosetron, dexamethasone, and 0.9% NaCl
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Dec 26, 2022

Chemo Induced Nausea and Vomiting Pediatric Cancer Patients Trial in Shanghai (Fosaprepitant, Placebo(normal saline))

Not yet recruiting
  • Chemotherapy Induced Nausea and Vomiting Pediatric Cancer Patients
  • Fosaprepitant
  • Placebo(normal saline)
  • Shanghai, China
    Shanghai Children's Medical Center
Jan 28, 2022

Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemo Trial (HR20013 for injection;dexamethasone, fosaprepitant

Not yet recruiting
  • Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy
  • HR20013 for injection；dexamethasone
  • fosaprepitant dimeglumine for injection；palonosetron hydrochloride injection；dexamethasone
  • (no location specified)
Aug 19, 2022

Traumatic Brain Injury Trial (Fosaprepitant)

Withdrawn
  • Traumatic Brain Injury
  • Fosaprepitant
  • (no location specified)
Oct 31, 2022

Olanzapine, CINV, Testicular Cancer by AJCC V6 and V7 Stage Trial in Guangzhou (Olanzapine Tablets, Placebo)

Recruiting
  • Olanzapine
  • +3 more
  • Olanzapine Tablets
  • Placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Feb 14, 2022

Pediatric Cancer Trial (Fosaprepitant, ondansetron with dexamethasone)

Not yet recruiting
  • Pediatric Cancer
  • Fosaprepitant
  • placebo ondansetron with dexamethasone
  • (no location specified)
Sep 1, 2021

Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy-induced Nausea and Vomiting
  • Hanzhou, Zhejiang, China
    the Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023

Chemo Induced Nausea and Vomiting, Pediatric Cancer Patients Trial in Shanghai (fosaprepitant, aprepitant, Granisetron plus

Not yet recruiting
  • Chemotherapy Induced Nausea and Vomiting
  • Pediatric Cancer Patients
  • fosaprepitant
  • +2 more
  • Shanghai, China
    Shanghai Children's Medical Center
May 5, 2021

Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 2, 2022

Gastrointestinal Cancer, Nausea Post Chemo Trial in Detroit (fosaprepitant dimeglumine)

Completed
Has Results
  • Gastrointestinal Cancer
  • Nausea Post Chemotherapy
  • fosaprepitant dimeglumine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 14, 2021

Nasopharyngeal Carcinoma Trial in Guangzhou (fosaprepitant)

Recruiting
  • Nasopharyngeal Carcinoma
  • fosaprepitant
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 17, 2020

Gynecologic Cancer Trial in Ann Arbor (Ondansetron, Dexamethasone, Neurokinin-1 Receptor Antagonist (NK1-RA))

Recruiting
  • Gynecologic Cancer
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jan 6, 2022

Chemo-induced Nausea and Vomiting Trial in Worldwide (Fosaprepitant Dimeglumine, 5-HT3 antagonist, Dexamethasone)

Completed
Has Results
  • Chemotherapy-induced Nausea and Vomiting
  • Fosaprepitant Dimeglumine
  • +2 more
  • Phoenix, Arizona
  • +25 more
Sep 22, 2021

Chemo-induced Nausea and Vomiting (CINV) Trial (Granisetron transdermal patch, Palonosetron, Aprepitant)

Not yet recruiting
  • Chemotherapy-induced Nausea and Vomiting (CINV)
  • Granisetron transdermal patch
  • +4 more
  • (no location specified)
Jun 2, 2021

Colorectal Cancer Trial in Japan (Aprepitant / Fosaprepitant)

Completed
  • Colorectal Cancer
  • Aprepitant / Fosaprepitant
  • Amagasaki, Hyogo, Japan
  • +26 more
Feb 25, 2021

Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemo Trial in China (olanzapine plus fosaprepitant-based triple

Unknown status
  • Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy
  • olanzapine plus fosaprepitant-based triple regimen
  • placebo plus fosaprepitant-based triple regimen
  • Beijing, China
  • +17 more
Aug 28, 2020

CINV Trial in Odense (Ondansetron, Placebo, Dexamethasone)

Completed
Has Results
  • CINV
  • Odense, Denmark
    Odense University Hospital
Nov 11, 2020

Locally Advanced Sarcoma Trial in Houston (Dexamethasone, Doxorubicin, Fosaprepitant Dimeglumine)

Terminated
Has Results
  • Locally Advanced Sarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 5, 2021

Malignant Tumor Trial in Guam, United States (Palonosetron Hydrochloride, Ondansetron Hydrochloride, Dexamethasone)

Active, not recruiting
  • Malignant Neoplasm
  • Palonosetron Hydrochloride
  • +5 more
  • Birmingham, Alabama
  • +565 more
Jan 6, 2022

Chemo-induced Nausea and Vomiting Trial (Fosaprepitant, Fosaprepitant Placebo, Ondansetron)

Completed
Has Results
  • Chemotherapy-induced Nausea and Vomiting
  • Fosaprepitant
  • +3 more
  • (no location specified)
Jun 14, 2019